BlackRock Advisors’s Kindred Biosciences, Inc. KIN Stock Holding History

BlackRock Advisors’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$99K	Sell	23,195 -1,201	-5%	-$5.81K	﹤0.01%	3045
2016 Q3	$122K	Sell	24,396 -1,775	-7%	-$7.5K	﹤0.01%	2935
2016 Q2	$93K	Buy	26,171 +1,453	+6%	+$5.34K	﹤0.01%	3004
2016 Q1	$85K	Buy	24,718 +4,986	+25%	+$17.6K	﹤0.01%	2988
2015 Q4	$67K	Buy	19,732 +1,043	+6%	+$4.84K	﹤0.01%	3096
2015 Q3	$97K	Sell	18,689 -60,407	-76%	-$372K	﹤0.01%	3116
2015 Q2	$539K	Sell	79,096 -6,555	-8%	-$46.5K	﹤0.01%	2124
2015 Q1	$612K	Buy	85,651 +693	+0.8%	+$4.78K	﹤0.01%	1930
2014 Q4	$633K	Buy	84,958 +14,567	+21%	+$124K	﹤0.01%	1818
2014 Q3	$651K	Buy	70,391 +65,923	+1,475%	+$891K	﹤0.01%	1754
2014 Q2	$83K	Sell	4,468 -699	-14%	-$11.9K	﹤0.01%	3140
2014 Q1	$96K	Buy	+5,167	New	+$98.5K	﹤0.01%	3049

Other funds holding KIN

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

BlackRock Advisors's KIN Position: Q4 2016 in Review

BlackRock Advisors reduced its Kindred Biosciences, Inc. (KIN) stake by 4.9% in Q4 2016, selling an estimated $5.81K and leaving 23,195 shares worth $99K. The position accounts for ﹤0.01% of the portfolio, ranked #3045.

BlackRock Advisors first reported a position in KIN in Q1 2014 and has held it in 12 quarters since. The position peaked at $651K in Q3 2014. 43 funds tracked by Wall St. Rank hold KIN as of Q4 2016.

BlackRock Advisors held 23,195 shares of Kindred Biosciences, Inc. worth $99K as of Q4 2016.
BlackRock Advisors sold 1,201 Kindred Biosciences, Inc. shares in Q4 2016, an estimated $5.81K.
Kindred Biosciences, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3045 holding.
BlackRock Advisors first reported a position in Kindred Biosciences, Inc. in Q1 2014 and has held it in 12 quarters since.
BlackRock Advisors's Kindred Biosciences, Inc. position peaked at $651K in Q3 2014.
43 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.